查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279738

2022-2029年全球静脉注射液市场规模研究和预测，按类型、按溶液成分和区域分析

Global Intravenous Solutions Market Size study & Forecast, by Type by Solution Composition and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

静脉（IV）溶液是通过静脉直接输入病人血液的无菌液体。它们通常用于医院、诊所和其他医疗环境，为无法口服这些物质的病人提供水分、药物、营养素或其他治疗剂。静脉注射液可以包含水、电解质、糖、维生素和药物的各种组合，这取决于病人的需要。它们有不同的浓度和类型，如等渗、低渗和高渗，这决定了它们对身体液体平衡的影响。推动市场增长的关键因素是营养不良的流行率上升，以及产品的进步和新的创新，以方便病人，预计将支持预测期间的市场增长。

此外，胃肠道疾病、神经系统疾病和癌症等疾病的流行，其中静脉注射液是患者的主要能量来源，是市场增长的主要贡献者之一。根据世界卫生组织的数据，2019年有37万人死亡，腹泻是五岁以下儿童死亡的第二大原因。此外，便携式包装的解决方案的可用性，使病人在舒适的家中而不是在医院使用点滴更简单，以及产品创新，如预混合解决方案，以提高便利性和减少包装废物量，是促进市场增长的其他几个因素。例如，2019年6月，专业输液和药品的制造商和经销商Eurolife Healthcare推出了用户友好和减少传染病的静脉注射设备Discport和Lifeport。此外，在预测期内，不断增长的老年人口预计将为市场创造有利可图的机会。然而，在2022-2029年的预测期内，缺乏有经验的医护人员和静脉给药治疗的并发症扼杀了市场增长。

全球静脉注射解决方案市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于主要市场参与者的存在，以及该地区老年人口的增加，北美是全球市场份额的主导地区。而亚太地区在预测期内也将表现出最高的增长率，这是因为慢性病发病率上升、各利益相关方之间的合作数量增加以及老龄人口增加等因素将为整个亚太地区的静脉注射液市场创造有利的增长前景。

该研究的目的是确定近年来不同领域和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球及细分市场的估计和预测
    • 2019-2029年，按地区分類的静脉注射液市场
    • 2019-2029年静脉注射液市场，按类型划分
    • 2019-2029年静脉注射液市场，按溶液成分划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球静脉注射液市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球静脉注射液市场动态

  • 静脉注射液市场影响分析（2019-2029）。
    • 市场驱动因素
      • 营养不良的流行率上升
      • 产品的进步和新的创新为病人带来便利
    • 市场挑战
      • 缺少有经验的医疗专业人员
      • 静脉注射疗法的并发症
    • 市场机会
      • 老年人口不断增加

第四章：全球静脉注射液市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球静脉注射液市场，按类型划分

  • 市场简介
  • 全球静脉注射液市场，按类型，性能-潜力分析
  • 2019-2029年全球静脉注射液市场按类型的估计和预测
  • 静脉注射液市场，次级細項分析
    • 全身肠外营养
    • 周边肠外营养

第7章 ：全球静脉注射液市场，按溶液成分分类

  • 市场简介
  • 按溶液成分分類的全球静脉注射液市场，性能-潜力分析
  • 2019-2029年全球静脉注射液市场按溶液成分估计和预测的情况
  • 静脉注射液市场，次级細項分析
    • 盐水
    • 碳水化合物
    • 维生素和矿物质
    • 其他溶液成分

第八章：全球静脉注射液市场，区域分析

  • 静脉注射液市场，区域市场简介
  • 北美洲
    • 美国
      • 2019-2029年，类型细分的估计和预测
      • 2019-2029年，溶液成分的细分估计和预测
    • 加拿大
  • 欧洲静脉注射液市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区静脉注射液市场简介
    • 中国
    • 中国
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲静脉注射液市场简况
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 世界其他地区

第九章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Amanta Healthcare Ltd.
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Axa Parenterals Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Dickinson and Company
    • Eurolife Healthcare Pvt Ltd.
    • Fresenius Kabi AG
    • Grifols S.A
    • Henry Schein Inc.
    • ICU Medical, Inc.

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.

Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.

Major market players included in this report are:

  • Amanta Healthcare Ltd.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dickinson and Company
  • Eurolife Healthcare Pvt Ltd.
  • Fresenius Kabi AG
  • Grifols S.A
  • Henry Schein Inc.
  • ICU Medical, Inc.

Recent Developments in the Market:

  • In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.

Global Intravenous Solutions Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Solution Composition, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

By Solution Composition:

  • Saline
  • Carbohydrates
  • Vitamins and Minerals
  • Other Solution Compositions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Intravenous Solutions Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Intravenous Solutions Market Dynamics

  • 3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in prevalence of malnutrition
      • 3.1.1.2. Advancements and new innovations in the products for patient convenience
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of experienced healthcare professionals
      • 3.1.2.2. Complications of intravenous administration therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing geriatric population

Chapter 4. Global Intravenous Solutions Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Intravenous Solutions Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
  • 6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Intravenous Solutions Market, Sub Segment Analysis
    • 6.4.1. Total Parenteral Nutrition
    • 6.4.2. Peripheral Parenteral Nutrition

Chapter 7. Global Intravenous Solutions Market, by Solution Composition

  • 7.1. Market Snapshot
  • 7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
  • 7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
  • 7.4. Intravenous Solutions Market, Sub Segment Analysis
    • 7.4.1. Saline
    • 7.4.2. Carbohydrates
    • 7.4.3. Vitamins and Minerals
    • 7.4.4. Other Solution Compositions

Chapter 8. Global Intravenous Solutions Market, Regional Analysis

  • 8.1. Intravenous Solutions Market, Regional Market Snapshot
  • 8.2. North America Intravenous Solutions Market
    • 8.2.1. U.S. Intravenous Solutions Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Intravenous Solutions Market
  • 8.3. Europe Intravenous Solutions Market Snapshot
    • 8.3.1. U.K. Intravenous Solutions Market
    • 8.3.2. Germany Intravenous Solutions Market
    • 8.3.3. France Intravenous Solutions Market
    • 8.3.4. Spain Intravenous Solutions Market
    • 8.3.5. Italy Intravenous Solutions Market
    • 8.3.6. Rest of Europe Intravenous Solutions Market
  • 8.4. Asia-Pacific Intravenous Solutions Market Snapshot
    • 8.4.1. China Intravenous Solutions Market
    • 8.4.2. India Intravenous Solutions Market
    • 8.4.3. Japan Intravenous Solutions Market
    • 8.4.4. Australia Intravenous Solutions Market
    • 8.4.5. South Korea Intravenous Solutions Market
    • 8.4.6. Rest of Asia Pacific Intravenous Solutions Market
  • 8.5. Latin America Intravenous Solutions Market Snapshot
    • 8.5.1. Brazil Intravenous Solutions Market
    • 8.5.2. Mexico Intravenous Solutions Market
    • 8.5.3. Rest of Latin America Intravenous Solutions Market
  • 8.6. Rest of The World Intravenous Solutions Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Amanta Healthcare Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Axa Parenterals Ltd.
    • 9.2.3. B. Braun Melsungen AG
    • 9.2.4. Baxter International Inc.
    • 9.2.5. Dickinson and Company
    • 9.2.6. Eurolife Healthcare Pvt Ltd.
    • 9.2.7. Fresenius Kabi AG
    • 9.2.8. Grifols S.A
    • 9.2.9. Henry Schein Inc.
    • 9.2.10. ICU Medical, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Intravenous Solutions Market, report scope
  • TABLE 2. Global Intravenous Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Intravenous Solutions Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Intravenous Solutions Market estimates & forecasts by Solution Composition 2019-2029 (USD Billion)
  • TABLE 5. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Intravenous Solutions Market
  • TABLE 70. List of primary sources, used in the study of global Intravenous Solutions Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Intravenous Solutions Market, research methodology
  • FIG 2. Global Intravenous Solutions Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Intravenous Solutions Market, key trends 2021
  • FIG 5. Global Intravenous Solutions Market, growth prospects 2022-2029
  • FIG 6. Global Intravenous Solutions Market, porters 5 force model
  • FIG 7. Global Intravenous Solutions Market, pest analysis
  • FIG 8. Global Intravenous Solutions Market, value chain analysis
  • FIG 9. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Intravenous Solutions Market, regional snapshot 2019 & 2029
  • FIG 15. North America Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Intravenous Solutions Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Intravenous Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable